search
Back to results

Synthetic Male Condom Slippage-Breakage Study

Primary Purpose

Contraceptive, Sexually Transmitted Diseases

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Test Product
Control Product
Sponsored by
Church & Dwight Company, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Contraceptive focused on measuring Synthetic Male Condom, Slippage-Breakage Study, ISO 29943-1

Eligibility Criteria

18 Years - 45 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Willing and able to give written or electronic informed consent
  • Willing to respond to questions concerning participant's reproductive and contraceptive history and use of condoms contained either on self-administered surveys or interviews
  • Agree to have vaginal intercourse at least once weekly
  • Protected against pregnancy by oral contraceptives, an intrauterine device (IUD), an implant, contraceptive injections, contraceptive patch, or sterilization (tubal ligation or vasectomy)
  • Willing to use the study products for eight acts of vaginal intercourse within four weeks of study entry
  • In a mutually monogamous relationship with participant's study partner for at least 3 months prior to screening and be willing to remain mutually monogamous throughout study participation
  • Agree not to use any vaginal or sexual lubricant except the product supplied by the study (AstroglideTM)
  • Agree not to wear any genital piercing jewellery while using the study condoms
  • Agree not to use sex toys or drugs intended to enhance or diminish sexual response when using study condoms
  • Agree to return any unopened condoms
  • Reachable by telephone
  • Has home internet access, a valid personal email for each partner, ability to videoconference and use electronic signature technology
  • Male partner agrees to ejaculate during vaginal intercourse

Exclusion Criteria:

  • Currently participating in another similar clinical study or employed by a condom manufacturer or Essential Access Health
  • Female partner self-reported as pregnant
  • Allergic to natural rubber latex or styrene-isoprene-styrene (SIS), or has a history of recurrent adverse events following use of latex or SIS products
  • Unable to follow instructions or strictly adhere to the visit schedule
  • At significant (high) risk of sexually transmitted infections, including human immunodeficiency virus (HIV) infection or having a medical history of recurrent, serious sexually transmitted infection (e.g., gonorrhea, syphilis, Chlamydia)
  • Currently using condoms for protection against a known sexually transmitted infection
  • Taking any externally applied medication or oral medication to treat a genital condition
  • Male partner has had difficulty achieving or maintaining an erection or achieving ejaculation in the last month prior to screening under typical circumstances/ conditions.
  • Any self-reported genital condition (e.g., itching, burning, irritation, etc.) which, in the opinion of the investigator, could affect the use of the study condoms or the ability to interpret study data

Sites / Locations

  • Essential Access HealthRecruiting
  • Essential Access HealthRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Test Product

Control Product

Arm Description

Synthetic Male Condom

Latex Male Condom

Outcomes

Primary Outcome Measures

Total Clinical Failure Rate
The number of condoms that broke or slipped completely off the penis during intercourse or withdrawal divided by the number of condoms used for vaginal intercourse.

Secondary Outcome Measures

Clinical Breakage Rate
The number of condoms that broke during intercourse or withdrawal divided by the number of condoms used for vaginal intercourse.
Clinical Complete Slippage Rate
The number of condoms that slipped completely off the penis during intercourse or withdrawal divided by the number of condoms used for vaginal intercourse.

Full Information

First Posted
May 4, 2022
Last Updated
March 2, 2023
Sponsor
Church & Dwight Company, Inc.
Collaborators
Essential Access Health
search

1. Study Identification

Unique Protocol Identification Number
NCT05370196
Brief Title
Synthetic Male Condom Slippage-Breakage Study
Official Title
Evaluation of the Functional Performance and Acceptability of a Synthetic Male Condom as Compared to a Commercial Latex Condom (Trojan-Enz)
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Recruiting
Study Start Date
June 10, 2022 (Actual)
Primary Completion Date
March 2023 (Anticipated)
Study Completion Date
April 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Church & Dwight Company, Inc.
Collaborators
Essential Access Health

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a multi-site, double-blind, crossover, randomized phase II study to evaluate the functional performance of a synthetic male condom as compared to a marketed latex condom.
Detailed Description
Approximately 300 heterosexual monogamous couples not at risk of pregnancy or transmission of sexually transmitted infections (STI) will be recruited to use both the test (synthetic) condom and a control (latex) condom. Couples will be given 4 condoms of one type (randomly determined) to use over a two week period, followed by 4 condoms of the other type to be used over the next two week period. The number of clinical failures (either condom breaks or completely slips off the penis) for each condom type will be compared to determine whether the test condom is non-inferior to the control condom. The study plan is based on International Standards Organization (ISO) guidance document ISO 29943-1 with the action standard set by synthetic condom standard ISO 23409.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Contraceptive, Sexually Transmitted Diseases
Keywords
Synthetic Male Condom, Slippage-Breakage Study, ISO 29943-1

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Masking Description
Each product will be labeled with a randomly generated code.
Allocation
Randomized
Enrollment
600 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Test Product
Arm Type
Experimental
Arm Description
Synthetic Male Condom
Arm Title
Control Product
Arm Type
Active Comparator
Arm Description
Latex Male Condom
Intervention Type
Device
Intervention Name(s)
Test Product
Other Intervention Name(s)
Synthetic Male Condom
Intervention Description
Synthetic Male Condom
Intervention Type
Device
Intervention Name(s)
Control Product
Other Intervention Name(s)
Latex Male Condom
Intervention Description
Latex Male Condom
Primary Outcome Measure Information:
Title
Total Clinical Failure Rate
Description
The number of condoms that broke or slipped completely off the penis during intercourse or withdrawal divided by the number of condoms used for vaginal intercourse.
Time Frame
Throughout the study. Each participating couple will engage in 8 acts over a 4 week period.
Secondary Outcome Measure Information:
Title
Clinical Breakage Rate
Description
The number of condoms that broke during intercourse or withdrawal divided by the number of condoms used for vaginal intercourse.
Time Frame
Throughout the study. Each participating couple will engage in 8 acts over a 4 week period.
Title
Clinical Complete Slippage Rate
Description
The number of condoms that slipped completely off the penis during intercourse or withdrawal divided by the number of condoms used for vaginal intercourse.
Time Frame
Throughout the study. Each participating couple will engage in 8 acts over a 4 week period.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Willing and able to give written or electronic informed consent Willing to respond to questions concerning participant's reproductive and contraceptive history and use of condoms contained either on self-administered surveys or interviews Agree to have vaginal intercourse at least once weekly Protected against pregnancy by oral contraceptives, an intrauterine device (IUD), an implant, contraceptive injections, contraceptive patch, or sterilization (tubal ligation or vasectomy) Willing to use the study products for eight acts of vaginal intercourse within four weeks of study entry In a mutually monogamous relationship with participant's study partner for at least 3 months prior to screening and be willing to remain mutually monogamous throughout study participation Agree not to use any vaginal or sexual lubricant except the product supplied by the study (AstroglideTM) Agree not to wear any genital piercing jewellery while using the study condoms Agree not to use sex toys or drugs intended to enhance or diminish sexual response when using study condoms Agree to return any unopened condoms Reachable by telephone Has home internet access, a valid personal email for each partner, ability to videoconference and use electronic signature technology Male partner agrees to ejaculate during vaginal intercourse Exclusion Criteria: Currently participating in another similar clinical study or employed by a condom manufacturer or Essential Access Health Female partner self-reported as pregnant Allergic to natural rubber latex or styrene-isoprene-styrene (SIS), or has a history of recurrent adverse events following use of latex or SIS products Unable to follow instructions or strictly adhere to the visit schedule At significant (high) risk of sexually transmitted infections, including human immunodeficiency virus (HIV) infection or having a medical history of recurrent, serious sexually transmitted infection (e.g., gonorrhea, syphilis, Chlamydia) Currently using condoms for protection against a known sexually transmitted infection Taking any externally applied medication or oral medication to treat a genital condition Male partner has had difficulty achieving or maintaining an erection or achieving ejaculation in the last month prior to screening under typical circumstances/ conditions. Any self-reported genital condition (e.g., itching, burning, irritation, etc.) which, in the opinion of the investigator, could affect the use of the study condoms or the ability to interpret study data
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Terri Walsh, MPH
Phone
213-386-5614
Ext
4589
Email
TWalsh@essentialaccess.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Terri Walsh, MPH
Organizational Affiliation
Essential Access Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
Essential Access Health
City
Berkeley
State/Province
California
ZIP/Postal Code
94710
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Terri Walsh, MPH
Phone
213-386-5614
Ext
4589
Email
TWalsh@essentialaccess.org
Facility Name
Essential Access Health
City
Los Angeles
State/Province
California
ZIP/Postal Code
90010
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Terri Walsh, MPH
Phone
213-386-5614
Ext
4589
Email
TWalsh@essentialaccess.org

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
If the participants enroll in this study, study staff will collect personal information about the participants. Study staff will protect information about participants and participant participation in this research study to the best of study staff ability. Study staff will assign participants a study number that study staff will use on all data collection forms in place of participants' names. Participant initials and date of birth may also be used on study forms to identify participants. If the results of this research are published, participants' names will not be shown. Study staff will follow institutional procedures for protecting privacy and promoting security during office, curbside exchange and videoconference visits.

Learn more about this trial

Synthetic Male Condom Slippage-Breakage Study

We'll reach out to this number within 24 hrs